Sg3 Management, LLC Pulmonx Corp Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $2.33 Million - $4.65 Million	-166,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $2.72 Million - $4.58 Million	128,500 Added 338.16%	166,500 $4.13 Million
Q4 2021 Feb 15, 2022	BUY	$29.72 - $45.1 $1.13 Million - $1.71 Million	38,000 New	38,000 $1.22 Million

124

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $233M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.